WebAssignee: ETHISMOS RESEARCH, INC. IPC: A61K31/403 Abstract: Provided are methods of using (1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form. Email; Share. Facebook; LinkedIn; Twitter; Note; 233 CN111969120A 一种包含芴衍生物的有机电致发光器件 ... WebMar 12, 2024 · Ethismos Research Anthony McKinney Current Workplace Anthony McKinney has been working as a Founder, President & Chief Executive Officer at …
Data on Ethismos Research Lead Compound, Amitifadine, …
WebApr 11, 2024 · Owns stock, stock options, or bonds from: Ethismos Research Inc.; S1 Biopharma, Inc. Dr Clayton does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States. Dr Clayton does not intend to discuss investigational drugs, mechanical devices, biologics, … WebMar 31, 2024 · The Post-Operative Pain pipeline market report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive … how to abbreviate the word commercial
Clinical Project Manager - Ethismos Research - LinkedIn
WebEthismos Research, Inc One Broadway Cambridge, MA 02142. Questions? Contact us ... WebMar 24, 2024 · Ethismos Research, Inc. is a clinical-stage drug development company developing pharmaceutical treatments for pain, … WebEthismos Research developing pharmaceutical treatments for chronic pain management, severe depression, and substance use disorders. Lists Featuring This Company Greater Boston Area Companies With Fewer Than 100 Employees (Top 10K) 9,944 Number of Organizations • $85.1B Total Funding Amount • 14,655 Number of Investors Track metal savintage sailship brass wall decor